Abstract
Pollen food allergy syndrome (PFAS) is widely prevalent, affecting 5 percent of the population(1). Subcutaneous allergen immunotherapy (SCIT) has been shown to be effective in reducing PFAS symptoms in adults(2). However, this effect has not been widely demonstrated in a pediatric population, which this study will examine.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
